Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2971 AL 2985

Multisite transcranial direct current stimulation in two patients with Alzheimer's disease: A 10-month follow-up study

de Almeida Rodrigues ET, da Silva Machado DG, Leon de Mendonça CTP, da Rocha Souto C, Ries A, Torro N, de Souza IC, Fernández-Calvo B, Andrade SM.

Neurophysiol Clin. 2020 Oct;50(5):393-395. doi: 10.1016/j.neucli.2020.08.001. Epub 2020 Aug 31.

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020)

Binda A, Murano C, Rivolta I.

Int J Nanomedicine. 2020 Aug 14;15:6113-6135. doi: 10.2147/IJN.S231480. eCollection 2020.

Memantine Derivatives as Multitarget Agents in Alzheimer's Disease

Marotta G, Basagni F, Rosini M, Minarini A.

Molecules. 2020 Sep 2;25(17):4005. doi: 10.3390/molecules25174005.

Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease

Nourbakhsh F, Read MI, Barreto GE, Sahebkar A.

IUBMB Life. 2020 Nov;72(11):2360-2281. doi: 10.1002/iub.2369. Epub 2020 Sep 7.

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer's Disease

Kim JY, Barua S, Jeong YJ, Lee JE.

Int J Mol Sci. 2020 Sep 3;21(17):6419. doi: 10.3390/ijms21176419.

Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis

Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R.

Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10.

Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: Evidence from the preclinical meta-analysis

Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK.

Brain Res. 2020 Dec 15;1749:147115. doi: 10.1016/j.brainres.2020.147115. Epub 2020 Sep 10.

Editorial: Establishing a Trial Ready Cohort to Accelerate Alzheimer's Clinical Trial Enrollment and Treatments

Meyers EA, Carrillo MC.

J Prev Alzheimers Dis. 2020;7(4):202-203. doi: 10.14283/jpad.2020.42.

Anticoagulants for Treatment of Alzheimer's Disease

Grossmann K.

J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.

Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer's disease

Guo M, Yin Z, Chen F, Lei P.

Alzheimers Res Ther. 2020 Sep 14;12(1):109. doi: 10.1186/s13195-020-00670-x.

Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease

Zhang Y, Zhao Y, Zhang J, Yang G.

Neurochem Res. 2020 Nov;45(11):2560-2572. doi: 10.1007/s11064-020-03121-z. Epub 2020 Sep 14.

Alzheimer's disease: natural products as inhibitors of neuroinflammation

Olajide OA, Sarker SD.

Inflammopharmacology. 2020 Dec;28(6):1439-1455. doi: 10.1007/s10787-020-00751-1. Epub 2020 Sep 15.

Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets

Uddin MS, Al Mamun A, Kabir MT, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM.

Mol Neurobiol. 2021 Jan;58(1):281-303. doi: 10.1007/s12035-020-02116-9. Epub 2020 Sep 15.

Alzheimer's disease: Recent treatment strategies

Vaz M, Silvestre S.

Eur J Pharmacol. 2020 Nov 15;887:173554. doi: 10.1016/j.ejphar.2020.173554. Epub 2020 Sep 15.

The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review

Zhang S, Zhu Q, Chen JY, OuYang D, Lu JH.

Phytomedicine. 2020 Dec;79:153316. doi: 10.1016/j.phymed.2020.153316. Epub 2020 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias